Observed Signal · Sep 30, 2026 · Market Signal · Source: Industrifonden · Impact: 2/5
Industrifonden participates in AnaCardio’s €62.5 million Series B
Industrifonden participates in AnaCardio’s €62.5 million Series B
Track Industrifonden Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Seed Capital closes €130M Fund V for Nordic startups
Copenhagen-based seed investor Seed Capital announced the closing of its fifth fund at €130 million, targeting 15-17 companies with first checks of €3-6 million in FinTech, cybersecurity, resilience, and AI-driven B2B sectors. The fund will expand beyond Denmark into the Nordics, with a strategic focus on Sweden. The firm also announced leadership changes: Christian Brøndum, former CEO of Planday, steps in as Managing Partner, and Geeta Schmidt, former CEO and co-founder of Humio, joins as General Partner. Seed Capital has already made initial investments from Fund V in Fortiv, Moxso, Repodo, and Oplane. The firm plans to evaluate opening a Swedish office to strengthen its close-to-founders approach. Its portfolio includes notable companies like Trustpilot, Flatpay, and Lunar.
Sofinnova Partners Closes €82M Medtech Fund MD Start IV
European life sciences venture capital firm Sofinnova Partners has closed its fourth medtech fund, Sofinnova MD Start IV, at €82 million. The oversubscribed fund will expand the firm's medtech company-creation strategy across Europe and the US, providing additional capacity to launch new ventures and support them through key development stages. Sofinnova plans to launch six to eight medtech companies through the fund over the next five years. The strategy combines clinical insight, entrepreneurial talent, and operational expertise to develop companies addressing unmet medical needs. The new fund follows Sofinnova MD Start III, a €63 million fund that invested across six companies, which collectively raised more than €140 million in follow-on financing. Notable portfolio companies include LimFlow, acquired by Inari Medical for up to $415 million, and PreCARDIA, acquired by Abiomed.
Copenhagen VC PSV Tech closes Fund II at €56 million
Copenhagen-based venture capital firm PSV Tech has announced the final close of its second fund, PSV Tech Fund II, at €56 million. The fund is dedicated to backing early-stage tech startups across the Nordics, often as a first institutional investor. The close builds on the success of Fund I, which made 47 investments, including portfolio companies Teton and Spektr that later raised €17 million Series A rounds. New investors in Fund II include Chr. Augustinus Fabrikker and Nordea-fonden, joining existing LPs such as ATP, EIFO, IDA, and prominent founders. PSV Tech has already made 19 investments from Fund II, with 11 in 2026 across Denmark, Sweden, and Norway. The firm is led by four General Partners and focuses on supporting Nordic founders before they achieve product-market fit.
Receive all future signals for Industrifonden & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.